Suppr超能文献

面对多种抗生素,尿路致病性大肠杆菌仍持续存在。

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

机构信息

Pathology Department, Division of Cell Biology and Immunology, University of Utah, Salt Lake City, UT 84112-0565, USA.

出版信息

Antimicrob Agents Chemother. 2010 May;54(5):1855-63. doi: 10.1128/AAC.00014-10. Epub 2010 Mar 15.

Abstract

Numerous antibiotics have proven to be effective at ameliorating the clinical symptoms of urinary tract infections (UTIs), but recurrent and chronic infections continue to plague many individuals. Most UTIs are caused by strains of uropathogenic Escherichia coli (UPEC), which can form both extra- and intracellular biofilm-like communities within the bladder. UPEC also persist inside host urothelial cells in a more quiescent state, sequestered within late endosomal compartments. Here, we tested a panel of 17 different antibiotics, representing seven distinct functional classes, for their effects on the survival of the reference UPEC isolate UTI89 within both biofilms and host bladder urothelial cells. All but one of the tested antibiotics prevented UTI89 growth in broth culture, and most were at least modestly effective against bacteria present within in vitro-grown biofilms. In contrast, only a few of the antibiotics, including nitrofurantoin and the fluoroquinolones ciprofloxacin and sparfloxacin, were able to eliminate intracellular bacteria in bladder cell culture-based assays. However, in a mouse UTI model system in which these antibiotics reached concentrations in the urine specimens that far exceeded minimal inhibitory doses, UPEC reservoirs in bladder tissues were not effectively eradicated. We conclude that the persistence of UPEC within the bladder, regardless of antibiotic treatments, is likely facilitated by a combination of biofilm formation, entry of UPEC into a quiescent or semiquiescent state within host cells, and the stalwart permeability barrier function associated with the bladder urothelium.

摘要

许多抗生素已被证明在改善尿路感染(UTI)的临床症状方面非常有效,但复发性和慢性感染仍困扰着许多人。大多数 UTI 是由尿路致病性大肠杆菌(UPEC)菌株引起的,这些菌株可以在膀胱内形成细胞外和细胞内的生物膜样群落。UPEC 还以更静止的状态存在于宿主尿路上皮细胞内,被隔离在晚期内体隔室中。在这里,我们测试了一组 17 种不同的抗生素,代表了七个不同的功能类别,以研究它们对参考 UPEC 分离株 UTI89 在生物膜和宿主膀胱尿路上皮细胞内的生存能力的影响。除了一种抗生素外,所有测试的抗生素都能阻止 UTI89 在肉汤培养物中的生长,而且大多数抗生素对体外生长的生物膜中存在的细菌至少有一定的抑制作用。相比之下,只有少数抗生素,包括呋喃妥因和氟喹诺酮类的环丙沙星和司帕沙星,能够在基于膀胱细胞培养的测定中消除细胞内细菌。然而,在一种小鼠 UTI 模型系统中,这些抗生素在尿液标本中的浓度远远超过了最小抑菌浓度,但膀胱组织中的 UPEC 库并没有被有效根除。我们得出结论,UPEC 在膀胱内的持续存在,无论是否使用抗生素治疗,都可能是由生物膜形成、UPEC 进入宿主细胞内的静止或半静止状态、以及与膀胱尿路上皮相关的坚韧通透性屏障功能的结合所促成的。

相似文献

1
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Antimicrob Agents Chemother. 2010 May;54(5):1855-63. doi: 10.1128/AAC.00014-10. Epub 2010 Mar 15.
3
Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli.
Cell Microbiol. 2006 Apr;8(4):704-17. doi: 10.1111/j.1462-5822.2006.00691.x.
6
Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic .
Infect Immun. 2024 May 7;92(5):e0008024. doi: 10.1128/iai.00080-24. Epub 2024 Mar 27.
7
10
Identification and Ranking of Clinical Compounds with Activity Against Log-phase Growing Uropathogenic Escherichia coli.
Curr Drug Discov Technol. 2020;17(2):191-196. doi: 10.2174/1570163815666180808115501.

引用本文的文献

2
Systematic design of pulse dosing to eradicate persister bacteria: The case of fluoroquinolones.
Comput Chem Eng. 2025 Apr;195. doi: 10.1016/j.compchemeng.2025.109010.
3
Sonoporation-enhanced the antibacterial efficacy of aminoglycosides against Gram-negative persisters.
World J Microbiol Biotechnol. 2025 Jul 2;41(7):241. doi: 10.1007/s11274-025-04414-7.
5
Harnessing traditional medicine: A dual-action antimicrobial combination against pathogens.
iScience. 2025 Mar 20;28(4):111910. doi: 10.1016/j.isci.2025.111910. eCollection 2025 Apr 18.
6
Nanogels conjugated with cell-penetrating peptide as drug delivery vehicle for treating urinary tract infections.
Nanomedicine. 2025 Apr;65:102812. doi: 10.1016/j.nano.2025.102812. Epub 2025 Feb 28.
7
Canine urothelial cell model to study intracellular bacterial community development by uropathogenic Escherichia coli.
PLoS One. 2025 Jan 9;20(1):e0316834. doi: 10.1371/journal.pone.0316834. eCollection 2025.
8
Immunoinformatics-driven design and computational analysis of a multiepitope vaccine targeting uropathogenic .
In Silico Pharmacol. 2024 Dec 21;13(1):2. doi: 10.1007/s40203-024-00288-z. eCollection 2025.
9
Nur77 protects the bladder urothelium from intracellular bacterial infection.
Nat Commun. 2024 Sep 27;15(1):8308. doi: 10.1038/s41467-024-52454-8.

本文引用的文献

1
Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli.
FEMS Microbiol Lett. 2010 Feb;303(1):33-40. doi: 10.1111/j.1574-6968.2009.01857.x. Epub 2009 Nov 17.
2
Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.
PLoS Pathog. 2009 Dec;5(12):e1000697. doi: 10.1371/journal.ppat.1000697. Epub 2009 Dec 18.
3
SOS response induces persistence to fluoroquinolones in Escherichia coli.
PLoS Genet. 2009 Dec;5(12):e1000760. doi: 10.1371/journal.pgen.1000760. Epub 2009 Dec 11.
4
TLR4-mediated expulsion of bacteria from infected bladder epithelial cells.
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14966-71. doi: 10.1073/pnas.0900527106. Epub 2009 Aug 17.
6
Cranberry and urinary tract infections.
Drugs. 2009;69(7):775-807. doi: 10.2165/00003495-200969070-00002.
7
Bacterial persistence: some new insights into an old phenomenon.
J Biosci. 2008 Dec;33(5):795-805. doi: 10.1007/s12038-008-0099-3.
8
Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway.
J Biol Chem. 2009 Jan 2;284(1):446-454. doi: 10.1074/jbc.M805010200. Epub 2008 Nov 6.
9
Growing and analyzing static biofilms.
Curr Protoc Microbiol. 2005 Jul;Chapter 1:Unit 1B.1. doi: 10.1002/9780471729259.mc01b01s00.
10
Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells.
Cell Microbiol. 2008 Dec;10(12):2553-67. doi: 10.1111/j.1462-5822.2008.01229.x. Epub 2008 Aug 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验